Bordetella pertussis Tohama phases I and III were grown to the late-exponential phase in liquid medium containing [3H]diaminopimelic acid and treated by a hot (96°C) sodium dodecyl sulfate extraction procedure. Washed sodium dodecyl sulfate-insoluble residue from phases I and III consisted of complexes containing protein (ca. 40%) and peptidoglycan (60%). Subsequent treatment with proteinase K yielded purified peptidoglycan which contained N-acetylglucosamine, N-acetylmuramic acid, alanine, glutamic acid, and diaminopimelic acid in molar ratios of 1:1:2:1:1 and <2% protein. Radiochemical analyses indicated that 3H added in diaminopimelic acid was present in peptidoglycan-protein complexes and purffied peptidoglycan as diaminopimelic acid exclusively and that pertussis peptidoglycan was not 0 acetylated, consistent with it being degraded completely by hen egg white lysozyme. Muramidase-derived disaccharide peptide monomers and peptide-cross-linked dimers and higher oligomers were isolated by molecular-sieve chromatography; from the distribution of these peptidoglycan fragments, the extent of peptide cross-linking of both phase I and III peptidoglycan was calculated to be ca. 48%. Unambiguous determination of the structure of muramidasederived peptidoglycan fragments by fast atom bombardment-mass spectrometry and tandem mass spectrometry indicated that the pertussis peptidoglycan monomer fraction was surprisingly homogeneous, consisting of >95% N-acetylglucosaminvl-N-acetylmuramyl-alanyl-glutamyl-diaminopimelyl-alanine.
Peptidoglycan (PG), a heteropolymer unique to bacterial cell walls, is well recognized as the principal determiner of bacterial shape and physical integrity (8) . However, although once regarded merely as an inert bacterial corset and as a target for penicillin action, it is now clear that PG fragments are potent modulators of inflammation and immunity in host tissues (see reference 27 for a review). Among the many diverse PG-mediated biological activities are adjuvanticity (2, 4) , arthropathic activity (6, 14) , enhancement of nonspecific resistance to infection and tumors (7, 13) , activation of macrophages (1, 29) , and (perhaps surprisingly) sleep-promoting activity (15, 16) .
During the course of studies in this laboratory on the role of PG in disease due to Neisseria gonorrhoeae (6, 18, 19, 22) , it came to our attention through the work of Goldman et al. (11) that there were certain functional similarities between gonococcal PG and PG derived from virulent Bordetella pertussis. Of particular interest was that each of these organisms released low-molecular-weight PG derivatives which promoted the loss of ciliated epithelial cells from mucosal surfaces (11, 18) . Human fallopian tube mucosa was employed as the model system in the case of gonococcal PG, whereas hamster trachea epithelium was the target tissue in the case of pertussis PG.
These findings raise the intriguing hypothesis that release of cytotoxic PG fragments might be a common denominator for at least some bacteria in which pathogenesis depends initially on colonization of ciliated mucosal surfaces. Our overall objective is to define the structural relationships which govern these functional similarities between gonococcal and pertussis PG. Fulfillment of such an objective would be compromised by the current lack of knowledge of the structure of B. pertussis PG. Accordingly, the specific aim of the current work is to provide these structural details. To obtain purified disaccharide peptide monomers and other low-molecular-weight PG fragments, purified intact pertussis PG was digested completely with N-acetylmuramidase from Streptomyces globisporus (muramidase SG; Miles Laboratories, Inc., Elkhart, Ind.) as described for gonococcal PG (23) . The muramidase-soluble monomers and peptide-cross-linked dimers and higher oligomers were separated as described previously (24, 28) for gonococcal PG fragments by gel filtration on connected columns of Sephadex G-50 and G-25 or by molecular-sieve high-performance liquid chromatography (HPLC) on connected columns of TSK SW3000 and TSK SW2000 (Varian, Palo Alto, Calif.). PG standards obtained from N. gonorrhoeae were prepared as described previously (18, 21, 24, 25, 28) .
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Analytical methods. The following procedures employed for chemical analysis of gonococcal PG have been applied to purified pertussis PG, PG-protein complexes, and lowmolecular-weight PG fragments as described previously: amino acid analysis with a Beckman model 119CL amino acid analyzer (24), paper chromatography in butanol-acetic acid-water (4:1:5; upper phase) for 17 h (or for 65 h in some experiments) or in 67% ethanol for 17 h (21, 24, 28), a-elimination of lactylpeptides from reducing PG fragments by treatment with 0.05 M NaOH (25, 30) , determination of percent peptide cross-linking (24) , and quantitation of the extent of 0 acetylation in PG fragments derived by sequential treatment of intact PG by muramidase SG and Escherichia coli endopeptidase (23, 28) .
Determination by fast atom bombardment-mass spectrometry and tandem mass spectrometry of the molecular weights and the complete sequences of PG monomers isolated by reversed-phase HPLC on a Vydac C18 column (Separations Group, Hesperia, Calif.) was performed as described previously (17) .
To (Fig.  1) . Furthermore, with the labeling regimen and culture conditions outlined above, the 3H was incorporated into the final purified PG at a very reasonable specific activity (greater than 106 dpm/mg). In preliminary experiments (data not shown), we found that under these conditions of growth [3H]DAP was incorporated into PG much more efficiently than was labeled glutamic acid, which had been used previously (11 (Table 2) , a relatively high value among PGs derived from gram-negative bacteria. There was no detectable difference in the extent of crosslinking between phase I and phase III PG. 0 acetylation and anhydromuramyl fragments. Labeled disaccharide peptide monomers were derived from purified PG by using muramidase SG alone or by using muramidase SG followed by E. coli endopeptidase. The former treatment permitted isolation of fragments which existed in intact PG as monomer subunits. The latter dual-enzyme procedure was employed to break peptide-cross-linking bonds (in addition to glycosidic bonds) and thereby to convert insoluble PG quantitatively to disaccharide peptide monomer subunits. Such monomers would include those that existed in native PG as the various cross-linked oligomers as well as those that existed as un-cross-linked monomers. The resulting monomeric fragments from either enzyme regimen were isolated and analyzed (i) to determine the distribution of 0-acetylated and non-O-acetylated subunits in pertussis PG and (ii) to evaluate for the presence of nonreducing anhydromuramic acid-containing fragments. The majority of pertussis PG monomers comigrated with the reducing (NaOHsensitive) non-O-acetylated disaccharide peptide standard (Fig. 2) , regardless of their derivation. In fact, we found no evidence for the presence of 0-acetylated subunits in pertussis PG. That is, only a small percentage of the 3H monomers derived by sequential muramidase-endopeptidase action comigrated with the labeled 0-acetylated monomer standard (Fig. 2) , and the small fraction that did comigrate was resistant to degradation by mild alkali. This compound was therefore not a reducing monomer containing an O-acetyl substituent in the number 6 position of muramic acid. Rather, this trace amount of NaOH-resistant monomer was most likely a nonreducing 1,6-anhydromuramyl PG derivative. Thus, pertussis PG was non-O-acetylated and possessed a small number of anhydromuramyl ends.
Muramidase sensitivity of PG and PG-protein. Extensive 0 acetylation characteristically renders PG resistant to egg white lysozyme relative to its non-O-acetylated counterpart (3, 10, 12, 28) ; then based on the above data, pertussis PG might be expected to be lysozyme sensitive. Indeed, purified pertussis PG from either phase III (Fig. 3) or phase I (data not shown) was degraded completely by egg white lysozyme as well as by muramidase SG, consistent with the structural evidence that it lacks O-acetyl substituents (Fig. 2) . PG- (Fig.  3) . Because purified 3H-PG was not degraded by proteinase K (Fig. 3) , there was no reason to believe that the proteinase was contaminated with PG hydrolase; because all of the 3H in PG-protein was present in DAP exclusively (Fig. 1) Structural analysis of purified disaccharide peptide monomers by fast atom bombardment-mass spectrometry and tandem mass spectrometry. Amino acid analysis revealed that the muramidase-derived monomer fraction from phase III bacteria was free of detectable non-PG contaminants and contained glucosamine, muramic acid, alanine, glutamic acid, and DAP in molar ratios similar to those of the intact PG from which it was derived (Table 1) . Reversed-phase HPLC further revealed that this muramidase-derived monomer fraction was a surprisingly homogeneous set of PG fragments. In fact, greater than 96% of the PG detected was present in only two peaks (Fig. 4) , which, when isolated and subjected to fast atom bombardment-mass spectrometry, both yielded the same parent protonated molecular ion, (M+H)+940 (Table 3) . Thus, the two peaks resolved by HPLC were anomers of a single compound with a mass of 939 daltons. The most probable structure of such a compound (Table 3) is N-acetylglucosaminyl-N-acetylmuramyl-alanyl--y-glutamyl-diaminopimelyl-alanine (NAG-NAM-Ala-Glu-DAP-Ala). Indeed, unambiguous structural determination of (M+H)+940 by tandem mass spectrometry verified this sequence. The mass spectrum of (M+H)+940 was practically identical to that of the same compound isolated from N. gonorrhoeae (17) . In addition to (M+H)+940, minor amounts of only three other PG monomers, including (M+H)+922, NAG-(1,6-anhydro)NAM-AlaGlu-DAP-Ala, were detected based on fast atom bombardment-mass spectrometry of peaks isolated by HPLC (Table  3) . Consistent with Fig. 2 , no 0-acetylated monomers were found.
It is not surprising that NAG-NAM-Ala-Glu-DAP-Ala was the principal compound detected among pertussis PG monomers, since this represents one of the more common subunit structures in gram-negative PG. However, given the extensive complexity of and diversity in analogous monomer preparations obtained from other gram-negative bacteria so far tested, e.g., E. coli (9, 20) and N. gonorrhoeae (5), B. pertussis PG subunits are remarkable for their apparent homogeneity.
The objective of this study was to provide structural details on PG derived from B. pertussis. We have found that pertussis PG (i) exists in complexes containing about 40% protein, (ii) has a gross composition reminiscent of classical consists almost exclusively of monomer subunits with the structure NAG-NAM-Ala-Glu-DAP-Ala, and (vii) appears structurally similar in both phase I and phase III organisms. The structural background provided by these data should enhance efforts to define the basis for the pertussis PGmediated toxicity to ciliated epithelium (11), a property which might conceivably be common to other pathogens that must colonize mucosal surfaces (18) .
